Visionary Investigators Network

The trials here

What the 13 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease9 trials
• Parkinson disease4 trials

Phase

• Phase 36 trials
• Phase 23 trials
• Phase 2/31 trial
• Phase 41 trial

Status

• Completed5 trials
• Active, not recruiting4 trials
• Recruiting3 trials
• Terminated1 trial

Lead sponsor

• Annovis Bio Inc.3 trials
• Eli Lilly and Company2 trials
• Novo Nordisk A/S2 trials
• Bristol-Myers Squibb1 trial
• GAP Innovations, PBC1 trial
• and 4 more

Running trials

• Active, not recruiting

  A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

  NCT07094516· Phase 2· Novartis Pharmaceuticals· Source

• Recruiting

  A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

  NCT07011745· Phase 3· Bristol-Myers Squibb· Source

  Contact: Jonathan Cross, Site 2648

• Recruiting

  A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

  NCT06765668· Phase 4· Impax Laboratories, LLC· Source

  Contact: Julie Schwartzbard

• Active, not recruiting

  A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD

  NCT06709014· Phase 3· Annovis Bio Inc.· Source

• Recruiting

  Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

  NCT06584357· GAP Innovations, PBC· Source

  Contact: Nicole Rios

• Active, not recruiting

  Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations

  NCT04006210· Phase 3· NeuroDerm Ltd.· Source

• Active, not recruiting

  A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)

  NCT02951598· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease2 recruiting
• Parkinson disease1 recruiting

Closed trials

• Completed

  A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease

  NCT06538116· Phase 2· Eli Lilly and Company· Source

• Completed

  A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD

  NCT05686044· Phase 2/3· Annovis Bio Inc.· Source

• Completed

  A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD

  NCT05357989· Phase 3· Annovis Bio Inc.· Source

• Completed

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

  NCT04777396· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

  NCT04777409· Phase 3· Novo Nordisk A/S· Source

• Terminated

  PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706

  NCT03655236· Phase 2· Sun Pharma Advanced Research Company Limited· Source